Avalyn Pharma Begins IPO Process For Pulmonary Fibrosis Pipeline

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.
Outlook Business

NSE to File DRHP by June, IPO May Raise Up to ₹23,000 Cr

National Stock Exchange (NSE) is set to file its DRHP by June 2026 for a long-awaited IPO that could raise up to ₹23,000 ...

NSE IPO: DRHP may be filed by June-end; listing targeted before December, says CNBC-TV18

National Stock Exchange's IPO process has accelerated significantly in recent months. The freshly reported timeline broadly ...

NSE begins IPO process, seeks shareholder interest for OFS participation

NSE starts IPO process, inviting shareholder interest for OFS participation with a response deadline of April 27.

Anthropic Targets October IPO in Potential $60 Billion Capital Raise

Anthropic is reportedly eyeing a massive October 2026 IPO, with bankers projecting a capital raise exceeding $60 billion.

SpaceX filing kicks off largest IPO process in history

Elon Musk’s rocket company SpaceX has confidentially filed to go public, firing the starting gun on what is expected to be ...
The Financial Express

Zepto nears final stages of SEBI’s in-principle nod for Rs 11,000 crore IPO

Zepto gets SEBI’s in-principle nod for Rs 11,000 crore IPO, with listing likely by June amid volatile markets and valuation ...

Space X kicks off IPO process with confidential filing

Elon Musk’s Space X has confidentially filed to go public, bringing the rocket company a step closer to delivering what is ...

NSE IPO Process Begins With OFS Notice, Shareholders Eligible Before June 15 Can Participate Until April 27

Not all shareholders can take part in this OFS. Only those who held NSE shares on or before June 15, 2025, are eligible. If someone bought shares after this date, they will not be allowed to ...